Skip to main content
Erschienen in: Endocrine 2/2016

01.02.2016 | Original Article

Morphological study of upper airways and long-term follow-up of obstructive sleep apnea syndrome in acromegalic patients

verfasst von: Cinzia Castellani, Giuseppe Francia, Luca Dalle Carbonare, Marcello Ferrari, Elena Viva, Roberto Cerini, Alessandro Zaccarella, Lorenzo Trevisiol, Maria Vittoria Davi’

Erschienen in: Endocrine | Ausgabe 2/2016

Einloggen, um Zugang zu erhalten

Abstract

Pathogenesis and long-term outcome of obstructive sleep apnea syndrome (OSAS) in acromegalic patients are still under debate. The aim of the study was to assess the prevalence and long-term follow-up of a series of acromegalic patients with OSAS and to investigate site, degree, and possible causes of upper airway obstruction by morphological study. Cross-sectional and longitudinal study was conducted in 58 acromegalic patients (33 active, 25 controlled) with polysomnography in all subjects, repeated in 25 patients with OSAS, and echocardiography. Morphological study including fiberoptic nasopharyngoscopy with the Müller maneuver (FNMM), magnetic resonance imaging (MRI), with 3-dimensional (3D) elaboration was also performed. The prevalence of OSAS was 58.6 % in the whole series: 63.6 % in the active group and 52 % in the controlled one. Left ventricular hypertrophy was more prevalent in patients with OSAS. OSAS improved in 62.5 % of active patients after achieving hormonal control, whereas it persisted or got worse in 66.6 % of the controlled ones. The uvula and tongue base were the main site of obstruction assessed by FNMM. Uvula diameters obtained by MRI study correlated with the severity of upper airway collapse assessed by FNMM and tongue measure with apnea–hypopnea index (p = 0.044). A greater narrowing and a smaller total volume of upper airways were confirmed by 3D-MRI in patients with more severe OSAS. Uvula and tongue hypertrophy plays a relevant role in the pathogenesis and severity of OSAS. Intensive treatment of acromegaly needs to be promptly adopted in order to reverse it.
Literatur
1.
Zurück zum Zitat R.R. Grunstein, K.Y. Ho, C.E. Sullivan, Sleep apnea in acromegaly. Ann. Intern. Med. 115, 527–532 (1991)CrossRefPubMed R.R. Grunstein, K.Y. Ho, C.E. Sullivan, Sleep apnea in acromegaly. Ann. Intern. Med. 115, 527–532 (1991)CrossRefPubMed
2.
Zurück zum Zitat L.M. Fatti, M. Sacchi, A.I. Pincelli, E. Lavezzi, F. Cavagnini, Prevalence and pathogenesis of sleep apnea and lung disease in acromegaly. Pituitary 4, 259–262 (2001)CrossRefPubMed L.M. Fatti, M. Sacchi, A.I. Pincelli, E. Lavezzi, F. Cavagnini, Prevalence and pathogenesis of sleep apnea and lung disease in acromegaly. Pituitary 4, 259–262 (2001)CrossRefPubMed
3.
Zurück zum Zitat V. Weiss, K. Sonka, M. Pretl, S. Dostalova, J. Klozar, P. Kambousek, J. Marek, T. Haas, Prevalence of the sleep apnea syndrome in acromegaly population. J. Endocrinol. Investig. 23, 515–519 (2000)CrossRef V. Weiss, K. Sonka, M. Pretl, S. Dostalova, J. Klozar, P. Kambousek, J. Marek, T. Haas, Prevalence of the sleep apnea syndrome in acromegaly population. J. Endocrinol. Investig. 23, 515–519 (2000)CrossRef
4.
Zurück zum Zitat T. Pekkarinen, M. Partinen, R. Pelkonen, M. Iivanainen, Sleep apnoea and daytime sleepiness in acromegaly: relationship to endocrinological factors. Clin. Endocrinol. 27, 649–654 (1987)CrossRef T. Pekkarinen, M. Partinen, R. Pelkonen, M. Iivanainen, Sleep apnoea and daytime sleepiness in acromegaly: relationship to endocrinological factors. Clin. Endocrinol. 27, 649–654 (1987)CrossRef
5.
Zurück zum Zitat W. Hochban, K. Ehlenz, R. Conradt, U. Brandenburg, Obstructive sleep apnoea in acromegaly: the role of craniofacial changes. Eur. Respir. J. 14, 196–202 (1999)CrossRefPubMed W. Hochban, K. Ehlenz, R. Conradt, U. Brandenburg, Obstructive sleep apnoea in acromegaly: the role of craniofacial changes. Eur. Respir. J. 14, 196–202 (1999)CrossRefPubMed
6.
Zurück zum Zitat M.V. Davi’, L. Dalle Carbonare, A. Giustina, M. Ferrari, A. Frigo, V.L. Cascio, G. Francia, Sleep apnoea syndrome is highly prevalent in acromegaly and only partially reversible after biochemical control of the disease. Eur. J. Endocrinol. 159(5), 533–540 (2008)CrossRefPubMed M.V. Davi’, L. Dalle Carbonare, A. Giustina, M. Ferrari, A. Frigo, V.L. Cascio, G. Francia, Sleep apnoea syndrome is highly prevalent in acromegaly and only partially reversible after biochemical control of the disease. Eur. J. Endocrinol. 159(5), 533–540 (2008)CrossRefPubMed
7.
Zurück zum Zitat M.V. Davi’, A. Giustina, Sleep apnea in acromegaly: a review on prevalence, pathogenetic aspects and treatment. Expert Rev. Endocrinol. Metab. 7(1), 55–62 (2012)CrossRef M.V. Davi’, A. Giustina, Sleep apnea in acromegaly: a review on prevalence, pathogenetic aspects and treatment. Expert Rev. Endocrinol. Metab. 7(1), 55–62 (2012)CrossRef
8.
Zurück zum Zitat P. Attal, P. Chanson, Endocrine aspects of obstructive sleep apnea. J. Clin. Endocrinol. Metab. 95, 483–495 (2010)CrossRefPubMed P. Attal, P. Chanson, Endocrine aspects of obstructive sleep apnea. J. Clin. Endocrinol. Metab. 95, 483–495 (2010)CrossRefPubMed
9.
Zurück zum Zitat F.R. Van Haute, G.F. Taboada, L.L. Corrêa, G.A. Lima, R. Fontes, A.P. Riello, M. Dominaci, M.R. Gadelha, Prevalence of sleep apnea and metabolic abnormalities in patients with acromegaly and analysis of cephalometric parameters by magnetic resonance imaging. Eur. J. Endocrinol. 158, 459–465 (2008)CrossRefPubMed F.R. Van Haute, G.F. Taboada, L.L. Corrêa, G.A. Lima, R. Fontes, A.P. Riello, M. Dominaci, M.R. Gadelha, Prevalence of sleep apnea and metabolic abnormalities in patients with acromegaly and analysis of cephalometric parameters by magnetic resonance imaging. Eur. J. Endocrinol. 158, 459–465 (2008)CrossRefPubMed
10.
Zurück zum Zitat D. Chemla, P. Attal, L. Maione, A.S. Veyer, G. Mroue, D. Baud, S. Salenave, P. Kamenicky, S. Bobin, P. Chanson, Impact of successful treatment of acromegaly on overnight heart rate variability and sleep apnea. J. Clin. Endocrinol. Metab. 99(8), 2925–2931 (2014)CrossRefPubMed D. Chemla, P. Attal, L. Maione, A.S. Veyer, G. Mroue, D. Baud, S. Salenave, P. Kamenicky, S. Bobin, P. Chanson, Impact of successful treatment of acromegaly on overnight heart rate variability and sleep apnea. J. Clin. Endocrinol. Metab. 99(8), 2925–2931 (2014)CrossRefPubMed
11.
Zurück zum Zitat A. Giustina, F.F. Casanueva, F. Cavagnini, P. Chanson, D. Clemmons, L.A. Frohman, R. Gaillard, K. Ho, P. Jaquet, D.L. Kleinberg, S.W. Lamberts, G. Lombardi, M. Sheppard, C.J. Strasburger, M.L. Vance, J.A. Wass, S. Melmed, Consensus: diagnosis and treatment of acromegaly complications. J. Endocrinol. Investig. 26, 1242–1247 (2003)CrossRef A. Giustina, F.F. Casanueva, F. Cavagnini, P. Chanson, D. Clemmons, L.A. Frohman, R. Gaillard, K. Ho, P. Jaquet, D.L. Kleinberg, S.W. Lamberts, G. Lombardi, M. Sheppard, C.J. Strasburger, M.L. Vance, J.A. Wass, S. Melmed, Consensus: diagnosis and treatment of acromegaly complications. J. Endocrinol. Investig. 26, 1242–1247 (2003)CrossRef
12.
Zurück zum Zitat A. Colao, D. Ferone, P. Marzullo, G. Lomabardi, Systemic complications of acromegaly: epidemiology, pathogenesis and management. Endocr. Rev. 25, 102–152 (2004)CrossRefPubMed A. Colao, D. Ferone, P. Marzullo, G. Lomabardi, Systemic complications of acromegaly: epidemiology, pathogenesis and management. Endocr. Rev. 25, 102–152 (2004)CrossRefPubMed
13.
14.
Zurück zum Zitat J.M. Marin, S.J. Carrizo, E. Vincente, A.G. Agusti, Long-term cardiovascular outcomes in men with obstructive sleep apnea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 365, 1046–1053 (2005)CrossRefPubMed J.M. Marin, S.J. Carrizo, E. Vincente, A.G. Agusti, Long-term cardiovascular outcomes in men with obstructive sleep apnea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 365, 1046–1053 (2005)CrossRefPubMed
15.
Zurück zum Zitat A.S. Shamsuzzaman, B.J. Gersh, V.K. Somers, Obstructive sleep apnea: implications for cardiac and vascular disease. J. Am. Med. Assoc. 290, 1906–1914 (2003)CrossRef A.S. Shamsuzzaman, B.J. Gersh, V.K. Somers, Obstructive sleep apnea: implications for cardiac and vascular disease. J. Am. Med. Assoc. 290, 1906–1914 (2003)CrossRef
16.
Zurück zum Zitat H.K. Yaggi, J. Concato, W.N. Kerman, J.H. Lichtman, L.M. Brass, V. Mohsenin, Obstructive sleep apnea as a risk factor for stroke and death. N. Engl. J. Med. 353, 2034–2041 (2005)CrossRefPubMed H.K. Yaggi, J. Concato, W.N. Kerman, J.H. Lichtman, L.M. Brass, V. Mohsenin, Obstructive sleep apnea as a risk factor for stroke and death. N. Engl. J. Med. 353, 2034–2041 (2005)CrossRefPubMed
17.
Zurück zum Zitat S. Isono, N. Saeki, A. Tanaka, T. Nishino, Collapsibility of passive pharynx in patients with acromegaly. Am. J. Respir Crit. Care Med. 160, 64–68 (1999)CrossRefPubMed S. Isono, N. Saeki, A. Tanaka, T. Nishino, Collapsibility of passive pharynx in patients with acromegaly. Am. J. Respir Crit. Care Med. 160, 64–68 (1999)CrossRefPubMed
18.
Zurück zum Zitat M.S.M. Ip, K.C.B. Tan, W.C.G. Peh, K.S.L. Lam, Effects of Sandostatin Lar on sleep apnoea in acromegaly: correlation with computerized tomographic cephalometry and hormonal activity. Clin. Endocrinol. 55, 477–483 (2001)CrossRef M.S.M. Ip, K.C.B. Tan, W.C.G. Peh, K.S.L. Lam, Effects of Sandostatin Lar on sleep apnoea in acromegaly: correlation with computerized tomographic cephalometry and hormonal activity. Clin. Endocrinol. 55, 477–483 (2001)CrossRef
19.
Zurück zum Zitat S. Dostalova, K. Sonka, Z. Smahel, V. Weiss, J. Marek, D. Horinek, Craniofacial abnormalities and their relevance for sleep apnoea syndrome aetiopathogenesis in acromegaly. Eur. J. Endocrinol. 144, 491–497 (2001)CrossRefPubMed S. Dostalova, K. Sonka, Z. Smahel, V. Weiss, J. Marek, D. Horinek, Craniofacial abnormalities and their relevance for sleep apnoea syndrome aetiopathogenesis in acromegaly. Eur. J. Endocrinol. 144, 491–497 (2001)CrossRefPubMed
20.
Zurück zum Zitat B.L. Herrmann, T.E. Wessendorf, W. Ajaj, S. Kahlke, H. Teschler, K. Mann, Effects of octreotide on sleep apnoea and tongue volume (magnetic resonance imaging) in patients with acromegaly. Eur. J. Endocrinol. 151, 309–315 (2004)CrossRefPubMed B.L. Herrmann, T.E. Wessendorf, W. Ajaj, S. Kahlke, H. Teschler, K. Mann, Effects of octreotide on sleep apnoea and tongue volume (magnetic resonance imaging) in patients with acromegaly. Eur. J. Endocrinol. 151, 309–315 (2004)CrossRefPubMed
21.
Zurück zum Zitat American Academy of Sleep Medicine Task Force Report, Sleeprelated breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. Sleep 22, 667–689 (1999) American Academy of Sleep Medicine Task Force Report, Sleeprelated breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. Sleep 22, 667–689 (1999)
22.
Zurück zum Zitat D.J. Terris, M.M. Hanasono, Y.C. Liu, Reliability of the Muller maneuver and its association with sleep-disordered breathing. Laryngoscope 110(11), 1819–1823 (2000)CrossRefPubMed D.J. Terris, M.M. Hanasono, Y.C. Liu, Reliability of the Muller maneuver and its association with sleep-disordered breathing. Laryngoscope 110(11), 1819–1823 (2000)CrossRefPubMed
23.
Zurück zum Zitat F. Rosenow, S. Reuter, U. Deuss, B. Szelies, R.D. Hilgers, W. Winkelmann, W.D. Heiss, Sleep apnoea in treated acromegaly: relative frequency and predisposing factors. Clin. Endocrinol. 45, 563–569 (1996)CrossRef F. Rosenow, S. Reuter, U. Deuss, B. Szelies, R.D. Hilgers, W. Winkelmann, W.D. Heiss, Sleep apnoea in treated acromegaly: relative frequency and predisposing factors. Clin. Endocrinol. 45, 563–569 (1996)CrossRef
24.
Zurück zum Zitat L. Sze, C. Schmid, K.E. Bloch, R. Bernays, M. Brandle, Effect of transsphenoidal surgery on sleep apnoea in acromegaly. Eur. J. Endocrinol. 156, 321–329 (2007)CrossRefPubMed L. Sze, C. Schmid, K.E. Bloch, R. Bernays, M. Brandle, Effect of transsphenoidal surgery on sleep apnoea in acromegaly. Eur. J. Endocrinol. 156, 321–329 (2007)CrossRefPubMed
25.
Zurück zum Zitat T. Young, J. Skatrud, P.E. Peppard, Risk factors for obstructive sleep apnea in adults. J. Am. Med. Assoc. 291, 2013–2016 (2004)CrossRef T. Young, J. Skatrud, P.E. Peppard, Risk factors for obstructive sleep apnea in adults. J. Am. Med. Assoc. 291, 2013–2016 (2004)CrossRef
26.
Zurück zum Zitat P.V. Tishler, E.K. Larkin, M.D. Schluchter, S. Redline, Incidence of sleep-disordered breathing in an urban adult population: the relative importance of risk factors in the development of sleep-disordered breathing. J. Am. Med. Assoc. 289, 2230–2237 (2003)CrossRef P.V. Tishler, E.K. Larkin, M.D. Schluchter, S. Redline, Incidence of sleep-disordered breathing in an urban adult population: the relative importance of risk factors in the development of sleep-disordered breathing. J. Am. Med. Assoc. 289, 2230–2237 (2003)CrossRef
27.
28.
Zurück zum Zitat G. Tolis, N.G. Angelopoulos, E. Katounda, G. Rombopoulos, V. Kaltzidou, D. Kalt, A. Protonotariou, A. Lytras, Medical treatment of acromegaly: comorbidities and their reversibility by somatostatin analogs. Neuroendocrinology 83, 249–257 (2006)CrossRefPubMed G. Tolis, N.G. Angelopoulos, E. Katounda, G. Rombopoulos, V. Kaltzidou, D. Kalt, A. Protonotariou, A. Lytras, Medical treatment of acromegaly: comorbidities and their reversibility by somatostatin analogs. Neuroendocrinology 83, 249–257 (2006)CrossRefPubMed
29.
Zurück zum Zitat N.M. Punjabi, V.Y. Polotsky, Disorders of glucose metabolism in sleep apnea. J. Appl. Physiol. 99, 1998–2007 (2005)CrossRefPubMed N.M. Punjabi, V.Y. Polotsky, Disorders of glucose metabolism in sleep apnea. J. Appl. Physiol. 99, 1998–2007 (2005)CrossRefPubMed
30.
Zurück zum Zitat C. Rajasoorya, I.M. Holdaway, P. Wrightson, D.J. Scott, H.K. Ibbertson, Determinants of clinical outcome and survival in acromegaly. Clin. Endocrinol. 41, 95–102 (1994)CrossRef C. Rajasoorya, I.M. Holdaway, P. Wrightson, D.J. Scott, H.K. Ibbertson, Determinants of clinical outcome and survival in acromegaly. Clin. Endocrinol. 41, 95–102 (1994)CrossRef
31.
Zurück zum Zitat R. Wolk, V.K. Somers, Cardiovascular consequences of obstructive sleep apnea. Clin. Chest Med. 24, 195–205 (2003)CrossRefPubMed R. Wolk, V.K. Somers, Cardiovascular consequences of obstructive sleep apnea. Clin. Chest Med. 24, 195–205 (2003)CrossRefPubMed
Metadaten
Titel
Morphological study of upper airways and long-term follow-up of obstructive sleep apnea syndrome in acromegalic patients
verfasst von
Cinzia Castellani
Giuseppe Francia
Luca Dalle Carbonare
Marcello Ferrari
Elena Viva
Roberto Cerini
Alessandro Zaccarella
Lorenzo Trevisiol
Maria Vittoria Davi’
Publikationsdatum
01.02.2016
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 2/2016
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-015-0659-x

Weitere Artikel der Ausgabe 2/2016

Endocrine 2/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.